Skip to main content

Advertisement

SpringerLink
Log in

Association between the CYP1A2 polymorphisms and risk of cancer: a meta-analysis

  • Original Paper
  • Published:
Molecular Genetics and Genomics Aims and scope Submit manuscript

Abstract

The previously published data on the association between CYP1A2*1C (rs2069514) and CYP1A2*1F (rs762551) polymorphisms and cancer risk have remained controversial. Hence, we performed a meta-analysis to investigate the association between CYP1A2*1F and CYP1A2*1C polymorphisms and cancer risk under different inheritance models. Overall, significant association was observed between CYP1A2*1F and cancer risk when all the eligible studies were pooled into the meta-analysis (dominant model: OR 1.08, 95 % CI 1.02–1.15; heterozygous model: OR 1.06, 95 % CI 1.01–1.12; additive model: OR 1.07, 95 % CI 1.02–1.13). In the further stratified and sensitivity analyses, for CYP1A2*1F polymorphism, significantly increased lung cancer risk and significantly decreased bladder cancer risk were observed in Caucasians. For CYP1A2*1C polymorphism, no significant association was found in overall and all subgroup analyses. In summary, this meta-analysis suggests that CYP1A2*1F polymorphism is associated with lung cancer and bladder cancer risk in Caucasians.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  • Aldrich MC, Selvin S, Hansen HM, Barcellos LF, Wrensch MR, Sison JD, Kelsey KT, Buffler PA, Quesenberry CP Jr, Seldin MF, Wiencke JK (2009) CYP1A1/2 haplotypes and lung cancer and assessment of confounding by population stratification. Cancer Res 69:2340–2348

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  • Altayli E, Gunes S, Yilmaz AF, Goktas S, Bek Y (2009) CYP1A2, CYP2D6, GSTM1, GSTP1, and GSTT1 gene polymorphisms in patients with bladder cancer in a Turkish population. Int Urol Nephrol 41:259–266

    Article  CAS  PubMed  Google Scholar 

  • Ayari I, Fedeli U, Saguem S, Hidar S, Khlifi S, Pavanello S (2013) Role of CYP1A2 polymorphisms in breast cancer risk in women. Mol Med Rep 7:280–286

    CAS  PubMed  Google Scholar 

  • Bae SY, Choi SK, Kim KR, Park CS, Lee SK, Roh HK, Shin DW, Pie JE, Woo ZH, Kang JH (2006) Effects of genetic polymorphisms of MDR1, FMO3 and CYP1A2 on susceptibility to colorectal cancer in Koreans. Cancer Sci 97:774–779

    Article  CAS  PubMed  Google Scholar 

  • Barbieri RB, Bufalo NE, Secolin R, Silva AC, Assumpção LV, Maciel RM, Cerutti JM, Ward LS (2012) Evidence that polymorphisms in detoxification genes modulate the susceptibility for sporadic medullary thyroid carcinoma. Eur J Endocrinol 166:241–245

    Article  CAS  PubMed  Google Scholar 

  • Barbieri RB, Bufalo NE, Cunha LL, Assumpção LV, Maciel RM, Cerutti JM, Ward LS (2013) Genes of detoxification are important modulators of hereditary medullary thyroid carcinoma risk. Clin Endocrinol (Oxf) 79:288–293

    Article  CAS  Google Scholar 

  • B’chir F, Pavanello S, Knani J, Boughattas S, Arnaud MJ, Saguem S (2009) CYP1A2 genetic polymorphisms and adenocarcinoma lung cancer risk in the Tunisian population. Life Sci 84:779–784

    Article  PubMed  Google Scholar 

  • Begg CB, Mazumdar M (1994) Operating characteristics of a rank correlation test for publication bias. Biometrics 50:1088–1101

    Article  CAS  PubMed  Google Scholar 

  • Brockstedt U, Krajinovic M, Richer C, Mathonnet G, Sinnett D, Pfau W et al (2002) Analyses of bulky DNA adduct levels in human breast tissue and genetic polymorphisms of cytochromes P450 (CYPs), myeloperoxidase (MPO), quinone oxidoreductase (NQO1), and glutathione S-transferases (GSTs). Mutat Res 516:41–47

    Article  CAS  PubMed  Google Scholar 

  • Catsburg C, Joshi AD, Corral R, Lewinger JP, Koo J, John EM, Ingles SA, Stern MC (2012) Polymorphisms in carcinogen metabolism enzymes, fish intake, and risk of prostate cancer. Carcinogenesis 33:1352–1359

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  • Chen K, Jin MJ, Fan CH, Song L, Jiang QT, Yu WP, Ma XY, Yao KY (2005) A case–control study on the association between genetic polymorphisms of metabolic enzymes and the risk of colorectal cancer. Zhonghua Liu Xing Bing Xue Za Zhi 26:659–664

    PubMed  Google Scholar 

  • Chen X, Wang H, Xie W, Liang R, Wei Z, Zhi L, Zhang X, Hao B, Zhong S, Zhou G, Zhang L, Gao X, Zhu Y, He F (2006) Association of CYP1A2 genetic polymorphisms with hepatocellular carcinoma susceptibility: a case–control study in a high-risk region of China. Pharmacogenet Genomics 16:219–227

    CAS  PubMed  Google Scholar 

  • Chida M, Yokoi T, Fukui T, Kinoshita M, Yokota J, Kamataki T (1999) Detection of three genetic polymorphisms in the 5’-flanking region and intron 1 of human CYP1A2 in the Japanese population. Jpn J Cancer Res 90:899–902

    Article  CAS  PubMed  Google Scholar 

  • Chiou HL, Wu MF, Chien WP, Cheng YW, Wong RH, Chen CY, Lin TS, Lee H (2005) NAT2 fast acetylator genotype is associated with an increased risk of lung cancer among never-smoking women in Taiwan. Cancer Lett 223:93–101

    Article  CAS  PubMed  Google Scholar 

  • Cleary SP, Cotterchio M, Shi E, Gallinger S, Harper P (2010) Cigarette smoking, genetic variants in carcinogen-metabolizing enzymes, and colorectal cancer risk. Am J Epidemiol 172:1000–1014

    Article  PubMed Central  PubMed  Google Scholar 

  • Pavanello S, Mastrangelo G, Placidi D, Campagna M, Pulliero A, Carta A, Arici C, Porru S (2010) CYP1A2 polymorphisms, occupational and environmental exposures and risk of bladder cancer. Eur J Epidemiol 25:491–500

    Article  CAS  PubMed  Google Scholar 

  • Cui X, Lu X, Hiura M, Omori H, Miyazaki W, Katoh T (2013) Association of genotypes of carcinogen-metabolizing enzymes and smoking status with bladder cancer in a Japanese population. Environ Health Prev Med 18:136–142

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  • Davey SG, Egger M (1997) Meta-analyses of randomized controlled trials. Lancet 350:1182

    Google Scholar 

  • De Roos AJ, Gold LS, Wang S, Hartge P, Cerhan JR, Cozen W, Yeager M, Chanock S, Rothman N, Severson RK (2006) Metabolic gene variants and risk of non-Hodgkin’s lymphoma. Cancer Epidemiol Biomarkers Prev 15:1647–1653

    Article  PubMed  Google Scholar 

  • DerSimonian R, Laird N (1986) Meta-analysis in clinical trials. Control Clin Trials 7:177–188

    Article  CAS  PubMed  Google Scholar 

  • Djordjevic N, Ghotbi R, Jankovic S, Aklillu E (2010a) Induction of CYP1A2 by heavy coffee consumption is associated with the CYP1A2 -163C>A polymorphism. Eur J Clin Pharmacol 66:697–703

    Article  CAS  PubMed  Google Scholar 

  • Djordjevic N, Carrillo JA, Gervasini G, Jankovic S, Aklillu E (2010b) In vivo evaluation of CYP2A6 and xanthine oxidase enzyme activities in the Serbian population. Eur J Clin Pharmacol 66:571–578

    Article  CAS  PubMed  Google Scholar 

  • Doherty JA, Weiss NS, Freeman RJ, Dightman DA, Thornton PJ, Houck JR, Voigt LF, Rossing MA, Schwartz SM, Chen C (2005) Genetic factors in catechol estrogen metabolism in relation to the risk of endometrial cancer. Cancer Epidemiol Biomarkers Prev 14:357–366

    Article  CAS  PubMed  Google Scholar 

  • Eaton DL, Gallagher EP, Bammler TK, Kunze KL (1995) Role of cytochrome P450 1A2 in chemical carcinogenesis: implications for human variability in expression and enzyme activity. Pharmacogenetics 5:259–274

    Article  CAS  PubMed  Google Scholar 

  • Egger M, Smith DG, Schneider M, Minder C (1997) Bias in meta-analysis detected by a simple, graphical test. Br Med J 315:629–634

    Article  CAS  Google Scholar 

  • Figueroa JD, Malats N, García-Closas M, Real FX, Silverman D, Kogevinas M, Chanock S, Welch R, Dosemeci M, Lan Q, Tardón A, Serra C, Carrato A, García-Closas R, Castaño-Vinyals G, Rothman N (2008) Bladder cancer risk and genetic variation in AKR1C3 and other metabolizing genes. Carcinogenesis 29:1955–1962

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  • Gemignani F, Landi S, Szeszenia-Dabrowska N, Zaridze D, Lissowska J, Rudnai P, Fabianova E, Mates D, Foretova L, Janout V, Bencko V, Gaborieau V, Gioia-Patricola L, Bellini I, Barale R, Canzian F, Hall J, Boffetta P, Hung RJ, Brennan P (2007) Development of lung cancer before the age of 50: the role of xenobiotic metabolizing genes. Carcinogenesis 28:1287–1293

    Article  CAS  PubMed  Google Scholar 

  • Gervasini G, Ghotbi R, Aklillu E, San Jose C, Cabanillas A, Kishikawa J, Benitez J, Carrillo JA (2013) Haplotypes in the 5’-untranslated region of the CYP1A2gene are inversely associated with lung cancer risk but do not correlate with caffeine metabolism. Environ Mol Mutagen 54:124–132

    Article  CAS  PubMed  Google Scholar 

  • Ghoshal U, Tripathi S, Kumar S, Mittal B, Chourasia D, Kumari N, Krishnani N, Ghoshal UC (2014) Genetic polymorphism of cytochrome P450 (CYP) 1A1, CYP1A2, and CYP2E1 genes modulate susceptibility to gastric cancer in patients with Helicobacter pylori infection. Gastric Cancer 17:226–234

    Article  CAS  PubMed  Google Scholar 

  • Goodman MT, McDuffie K, Kolonel LN, Terada K, Donlon TA, Wilkens LR, Guo C, Le Marchand L (2001) Case–control study of ovarian cancer and polymorphisms in genes involved in catecholestrogen formation and metabolism. Cancer Epidemiol Biomarkers Prev 10:209–216

    CAS  PubMed  Google Scholar 

  • Guengerich FP (2001) Forging the links between metabolism and carcinogenesis. Mutat Res 488:195–209

    Article  CAS  PubMed  Google Scholar 

  • Landi MT, Sinha R, Lang NP, Landi MT, Sinha R, Lang NP, Kadlubar FF (1999) Human cytochrome P4501A2. In: Vineis P, Malats N, Lang M (eds) Metabolic polymorphisms and susceptibility to cancer, vol Chapter 16, 148th edn. IARC Scientific Publications, IARC, Lyon, pp 173–195

    Google Scholar 

  • Gulyaeva LF, Mikhailova ON, PustyInyak VO, Kim IV 4th, Gerasimov AV, Krasilnikov SE, Filipenko ML, Pechkovsky EV (2008) Comparative analysis of SNP in estrogen-metabolizing enzymes for ovarian, endometrial, and breast cancers in Novosibirsk, Russia. Adv Exp Med Biol 617:359–366

    Article  CAS  PubMed  Google Scholar 

  • Han XM, Ouyang DS, Chen XP, Shu Y, Jiang CH, Tan ZR et al (2002) Inducibility of CYP1A2 by omeprazole in vivo related to the genetic polymorphism of CYP1A2. Br J Clin Pharmacol 54:540–543

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  • Higgins JPT, Green S (2008) Cochrane handbook for systematic reviews of interventions version 5.0.1. The Cochrane Collaboration, Oxford

  • Hirschhorn JN, Lohmueller K, Byrne E (2002) A comprehensive review of genetic association studies. Genet Med 4:45–61

    Article  CAS  PubMed  Google Scholar 

  • Higgins JP, Thompson SG, Deeks JJ, Altman DG (2003) Measuring inconsistency in meta-analysis. Br Med J 327:557–560

    Article  Google Scholar 

  • Hirata H, Hinoda Y, Okayama N, Suehiro Y, Kawamoto K, Kikuno N, Rabban JT, Chen LM, Dahiya R (2008) CYP1A1, SULT1A1, and SULT1E1 polymorphisms are risk factors for endometrial cancer susceptibility. Cancer 112:1964–1973

    Article  CAS  PubMed  Google Scholar 

  • Imaizumi T, Higaki Y, Hara M, Sakamoto T, Horita M, Mizuta T, Eguchi Y, Yasutake T, Ozaki I, Yamamoto K, Onohara S, Kawazoe S, Shigematsu H, Koizumi S, Kudo S, Tanaka K (2009) Interaction between cytochrome P450 1A2 genetic polymorphism and cigarette smoking on the risk of hepatocellular carcinoma in a Japanese population. Carcinogenesis 30:1729–1734

    Article  CAS  PubMed  Google Scholar 

  • Jang JH, Cotterchio M, Borgida A, Gallinger S, Cleary SP (2012) Genetic variants in carcinogen-metabolizing enzymes, cigarette smoking and pancreatic cancer risk. Carcinogenesis 33:818–827

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  • Khvostova EP, Pustylnyak VO, Gulyaeva LF (2012) Genetic polymorphism of estrogen metabolizing enzymes in Siberian women with breast cancer. Genet Test Mol Biomarkers 16:167–173

    Article  CAS  PubMed  Google Scholar 

  • Kiss I, Orsós Z, Gombos K, Bogner B, Csejtei A, Tibold A, Varga Z, Pázsit E, Magda I, Zölyomi A, Ember I (2007) Association between allelic polymorphisms of metabolizing enzymes (CYP 1A1, CYP 1A2, CYP 2E1, mEH) and occurrence of colorectal cancer in Hungary. Anticancer Res 27:2931–2937

    CAS  PubMed  Google Scholar 

  • Kobayashi M, Otani T, Iwasaki M, Natsukawa S, Shaura K, Koizumi Y, Kasuga Y, Sakamoto H, Yoshida T, Tsugane S (2009a) Association between dietary heterocyclic amine levels, genetic polymorphisms of NAT2, CYP1A1, and CYP1A2 and risk of stomach cancer: a hospital-based case–control study in Japan. Gastric Cancer 12:198–205

    Article  CAS  PubMed  Google Scholar 

  • Kobayashi M, Otani T, Iwasaki M, Natsukawa S, Shaura K, Koizumi Y, Kasuga Y, Sakamoto H, Yoshida T, Tsugane S (2009b) Association between dietary heterocyclic amine levels, genetic polymorphisms of NAT2, CYP1A1, and CYP1A2 and risk of colorectal cancer: a hospital-based case–control study in Japan. Scand J Gastroenterol 44:952–959

    Article  CAS  PubMed  Google Scholar 

  • Kotsopoulos J, Ghadirian P, El-Sohemy A, Lynch HT, Snyder C, Daly M, Domchek S, Randall S, Karlan B, Zhang P, Zhang S, Sun P, Narod SA (2007) The CYP1A2 genotype modifies the association between coffee consumption and breast cancer risk among BRCA1 mutation carriers. Cancer Epidemiol Biomarkers Prev 16:912–916

    Article  CAS  PubMed  Google Scholar 

  • Kotsopoulos J, Vitonis AF, Terry KL, De Vivo I, Cramer DW, Hankinson SE, Tworoger SS (2009) Coffee intake, variants in genes involved in caffeine metabolism, and the risk of epithelial ovarian cancer. Cancer Causes Control 20:335–344

    Article  PubMed Central  PubMed  Google Scholar 

  • Küry S, Buecher B, Robiou-du-Pont S, Scoul C, Sébille V, Colman H, Le Houérou C, Le Neel T, Bourdon J, Faroux R, Ollivry J, Lafraise B, Chupin LD, Bézieau S (2007) Combinations of cytochrome P450 gene polymorphisms enhancing the risk for sporadic colorectal cancer related to red meat consumption. Cancer Epidemiol Biomarkers Prev 16:1460–1467

    Article  PubMed  Google Scholar 

  • Landi S, Gemignani F, Moreno V, Gioia-Patricola L, Chabrier A, Guino E, Navarro M, de Oca J, Capellà G, Canzian F, Bellvitge Colorectal Cancer Study Group (2005) A comprehensive analysis of phase I and phase II metabolism gene polymorphisms and risk of colorectal cancer. Pharmacogenet Genomics 15:535–546

    Article  CAS  PubMed  Google Scholar 

  • Le Marchand L, Donlon T, Kolonel LN, Henderson BE, Wilkens LR (2005) Estrogen metabolism-related genes and breast cancer risk: the multiethnic cohort study. Cancer Epidemiol Biomarkers Prev 14:1998–2003

    Article  PubMed  Google Scholar 

  • Lee HJ, Wu K, Cox DG, Hunter D, Hankinson SE, Willett WC, Sinha R, Cho E (2013) Polymorphisms in xenobiotic metabolizing genes, intakes of heterocyclic amines and red meat, and postmenopausal breast cancer. Nutr Cancer 65:1122–1131

    Article  CAS  PubMed  Google Scholar 

  • Li D, Jiao L, Li Y, Doll MA, Hein DW, Bondy ML, Evans DB, Wolff RA, Lenzi R, Pisters PW, Abbruzzese JL, Hassan MM (2006) Polymorphisms of cytochrome P4501A2 and N-acetyltransferase genes, smoking, and risk of pancreatic cancer. Carcinogenesis 27:103–111

    Article  PubMed Central  PubMed  Google Scholar 

  • Long JR, Egan KM, Dunning L, Shu XO, Cai Q, Cai H, Dai Q, Holtzman J, Gao YT, Zheng W (2006) Population-based case–control study of AhR (aryl hydrocarbon receptor) and CYP1A2 polymorphisms and breast cancer risk. Pharmacogenet Genomics 16:237–243

    Article  CAS  PubMed  Google Scholar 

  • Lowcock EC, Cotterchio M, Anderson LN, Boucher BA, El-Sohemy A (2013) High coffee intake, but not caffeine, is associated with reduced estrogen receptor negative and postmenopausal breast cancer risk with no effect modification by CYP1A2 genotype. Nutr Cancer 65:398–409

    Article  CAS  PubMed  Google Scholar 

  • Mantel N, Haenszel W (1959) Statistical aspects of the analysis of data from retrospective studies of disease. Natl Cancer Inst 22:719–748

    CAS  Google Scholar 

  • MARIE-GENICA Consortium on Genetic Susceptibility for Menopausal Hormone Therapy Related Breast Cancer Risk (2010) Genetic polymorphisms in phase I and phase II enzymes and breast cancer risk associated with menopausal hormone therapy in postmenopausal women. Breast Cancer Res Treat 119:463–474

    Article  Google Scholar 

  • McManus ME, Burgess WM, Veronese ME, Huggett A, Quattrochi LC, Tukey RH (1990) Metabolism of 2-acetylaminofluorene and benzo(a)pyrene and activation of food-derived heterocyclic amine mutagens by human cytochromes P-450. Cancer Res 50:3367–3376

    CAS  PubMed  Google Scholar 

  • Mikhailova ON, Gulyaeva LF, Prudnikov AV, Gerasimov AV, Krasilnikov SE (2006) Estrogen-metabolizing gene polymorphisms in the assessment of female hormone-dependent cancer risk. Pharmacogenomics J 6:189–193

    Article  CAS  PubMed  Google Scholar 

  • Mochizuki J, Murakami S, Sanjo A, Takagi I, Akizuki S, Ohnishi A (2005) Genetic polymorphisms of cytochrome P450 in patients with hepatitis C virus-associated hepatocellular carcinoma. J Gastroenterol Hepatol 20:1191–1197

    Article  CAS  PubMed  Google Scholar 

  • Nakajima M, Yokoi T, Mizutani M, Kinoshita M, Funayama M, Kamataki T (1999) Genetic polymorphism in the 5’-flanking region of humanCYP1A2 gene: effect on the CYP1A2 inducibility in humans. J Biochem 125:803–808

    Article  CAS  PubMed  Google Scholar 

  • Obase Y, Shimoda T, Kawano T, Saeki S, Tomari SY, MitsutaIzaki K et al (2003) Polymorphisms in the CYP1A2 gene and theophylline metabolism in patients with asthma. Clin Pharmacol Ther 73:468–474

    Article  CAS  PubMed  Google Scholar 

  • Osawa Y, Osawa KK, Miyaishi A, Higuchi M, Tsutou A, Matsumura S, Tabuchi Y, Tsubota N, Takahashi J (2007) NAT2 and CYP1A2 polymorphisms and lung cancer risk in relation to smoking status. Asian Pac J Cancer Prev 8:103–108

    PubMed  Google Scholar 

  • Pavanello S, Fedeli U, Mastrangelo G, Rota F, Overvad K, Raaschou-Nielsen O, Tjønneland A, Vogel U (2012) Role of CYP1A2 polymorphisms on lung cancer risk in a prospective study. Cancer Genet 205:278–284

    Article  CAS  PubMed  Google Scholar 

  • Pilgrim JL, Ruiz Y, Gesteira A, Cruz R, Gerostamoulos D, Carracedo A et al (2012) Characterization of single nucleotide polymorphisms of cytochrome p450 in an Australian deceased sample. Curr Drug Metab 13:679–692

    Article  CAS  PubMed  Google Scholar 

  • Prawan A, Kukongviriyapan V, Tassaneeyakul W, Pairojkul C, Bhudhisawasdi V (2005) Association between genetic polymorphisms of CYP1A2, arylamine N-acetyltransferase 1 and 2 and susceptibility to cholangiocarcinoma. Eur J Cancer Prev 14:245–250

    Article  CAS  PubMed  Google Scholar 

  • Rebbeck TR, Troxel AB, Wang Y, Walker AH, Panossian S, Gallagher S, Shatalova EG, Blanchard R, Bunin G, DeMichele A, Rubin SC, Baumgarten M, Berlin M, Schinnar R, Berlin JA, Strom BL (2006) Estrogen sulfation genes, hormone replacement therapy, and endometrial cancer risk. J Natl Cancer Inst 98:1311–1320

    Article  CAS  PubMed  Google Scholar 

  • Rudolph A, Sainz J, Hein R, Hoffmeister M, Frank B, Försti A, Brenner H, Hemminki K, Chang-Claude J (2011) Modification of menopausal hormone therapy-associated colorectal cancer risk by polymorphisms in sex steroid signaling, metabolism and transport related genes. Endocr Relat Cancer 18:371–384

    Article  CAS  PubMed  Google Scholar 

  • Sachse C, Smith G, Wilkie MJ, Barrett JH, Waxman R, Sullivan F, Forman D, Bishop DT, Wolf CR, Colorectal Cancer Study Group (2002) A pharmacogenetic study to investigate the role of dietary carcinogens in the etiology of colorectal cancer. Carcinogenesis 23:1839–1849

    Article  CAS  PubMed  Google Scholar 

  • Sachse C, Brockmoller J, Bauer S, Roots I (1999) Functional significance of a C– > A polymorphism in intron 1 of the cytochrome P450 CYP1A2 gene tested with caffeine. Br J Clin Pharmacol 47:445–449

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  • Saebø M, Skjelbred CF, Brekke Li K, Bowitz Lothe IM, Hagen PC, Johnsen E, Tveit KM, Kure EH (2008) CYP1A2 164 A- > C polymorphism, cigarette smoking, consumption of well-done red meat and risk of developing colorectal adenomas and carcinomas. Anticancer Res 28:2289–2295

    PubMed  Google Scholar 

  • Sainz J, Rudolph A, Hein R, Hoffmeister M, Buch S, von Schönfels W, Hampe J, Schafmayer C, Völzke H, Frank B, Brenner H, Försti A, Hemminki K, Chang-Claude J (2011) Association of genetic polymorphisms in ESR2, HSD17B1, ABCB1, and SHBG genes with colorectal cancer risk. Endocr Relat Cancer 18:265–276

    Article  CAS  PubMed  Google Scholar 

  • Goodman MT, Tung KH, McDuffie K, Wilkens LR, Donlon TA (2003) Association of caffeine intake and CYP1A2 genotype with ovarian cancer. Nutr Cancer 46:23–29

    Article  CAS  PubMed  Google Scholar 

  • Sangrajrang S, Sato Y, Sakamoto H, Ohnami S, Laird NM, Khuhaprema T, Brennan P, Boffetta P, Yoshida T (2009) Genetic polymorphisms of estrogen metabolizing enzyme and breast cancer risk in Thai women. Int J Cancer 125:837–843

    Article  CAS  PubMed  Google Scholar 

  • Singh AP, Pant MC, Ruwali M, Shah PP, Prasad R, Mathur N, Parmar D (2010) –2011) Polymorphism in cytochrome P450 1A2 and their interaction with risk factors in determining risk of squamous cell lung carcinoma in men. Cancer 8:351–359

    CAS  Google Scholar 

  • Smith CA, Smith G, Wolf CR (1994) Genetic polymorphisms in xenobiotic metabolism. Eur J Cancer 30A:1921–1935

    Article  CAS  PubMed  Google Scholar 

  • Suzuki H, Morris JS, Li Y, Doll MA, Hein DW, Liu J, Jiao L, Hassan MM, Day RS, Bondy ML, Abbruzzese JL, Li D (2008) Interaction of the cytochrome P4501A2, SULT1A1 and NAT gene polymorphisms with smoking and dietary mutagen intake in modification of the risk of pancreatic cancer. Carcinogenesis 29:1184–1191

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  • Takata K, Saruwatari J, Nakada N, Nakagawa M, Fukuda K, Tanaka F et al (2006) Phenotype-genotype analysis of CYP1A2 in Japanese patients receiving oral theophylline therapy. Eur J Clin Pharmacol 62:23–28

    Article  CAS  PubMed  Google Scholar 

  • Takata Y, Maskarinec G, Le Marchand L (2007) Breast density and polymorphisms in genes coding for CYP1A2 and COMT: the multiethnic cohort. BMC Cancer 7:30

    Article  PubMed Central  PubMed  Google Scholar 

  • Tian Z, Li YL, Zhao L, Zhang CL (2013) Role of CYP1A2 1F polymorphism in cancer risk: evidence from a meta-analysis of 46 case–control studies. Gene 524:168–174

    Article  CAS  PubMed  Google Scholar 

  • Tsukino H, Kuroda Y, Nakao H, Imai H, Inatomi H, Osada Y, Katoh T (2004) Cytochrome P450 (CYP) 1A2, sulfotransferase (SULT) 1A1, and N-acetyltransferase (NAT) 2 polymorphisms and susceptibility to urothelial cancer. J Cancer Res Clin Oncol 130:99–106

    Article  CAS  PubMed  Google Scholar 

  • Villanueva CM, Silverman DT, Murta-Nascimento C, Malats N, Garcia-Closas M, Castro F, Tardon A, Garcia-Closas R, Serra C, Carrato A, Rothman N, Real FX, Dosemeci M, Kogevinas M (2009) Coffee consumption, genetic susceptibility and bladder cancer risk. Cancer Causes Control 20:121–127

    Article  PubMed Central  PubMed  Google Scholar 

  • Wang J, Joshi AD, Corral R, Siegmund KD, Marchand LL, Martinez ME, Haile RW, Ahnen DJ, Sandler RS, Lance P, Stern MC (2012a) Carcinogen metabolism genes, red meat and poultry intake, and colorectal cancer risk. Int J Cancer 130:1898–1907

    Article  CAS  PubMed  Google Scholar 

  • Wang HG, Zhang Z, Han SG, Lu YJ, Feng FM, Yuan JX (2012b) CYP1A2 rs762551 polymorphism contributes to cancer susceptibility: a meta-analysis from 19 case–control studies. BMC Cancer 12:528

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  • Wang L, Hu Z, Deng X, Wang Y, Zhang Z, Cheng ZN (2013) Association between common CYP1A2 polymorphisms and theophylline metabolism in non-smoking healthy volunteers. Basic Clin Pharmacol Toxicol 112:257–263

    Article  CAS  PubMed  Google Scholar 

  • Wei W, Ge JP, Dong J, Gao JP, Zhang ZY, Gong J (2011) Single nucleotide polymorphisms of CYP1A2 and their correlation with prostate cancer. Zhonghua Nan Ke Xue 17:998–1001

    CAS  PubMed  Google Scholar 

  • Windmill KF, McKinnon RA, Zhu X, Gaedigk A, Grant DM, McManus ME (1997) The role of xenobiotic metabolizing enzymes in arylamine toxicity and carcinogenesis: functional and localization studies. Mutat Res 376:153–160

    Article  CAS  PubMed  Google Scholar 

  • Klug SJ, Ressing M, Koenig J, Abba MC, Agorastos T, Brenna SM, Ciotti M, Das BR, Del Mistro A, Dybikowska A, Giuliano AR, Gudleviciene Z, Gyllensten U, Haws AL, Helland A, Herrington CS, Hildesheim A, Humbey O, Jee SH, Kim JW, Madeleine MM, Menczer J, Ngan HY, Nishikawa A, Niwa Y, Pegoraro R, Pillai MR, Ranzani G, Rezza G, Rosenthal AN, Roychoudhury S, Saranath D, Schmitt VM, Sengupta S, Settheetham-Ishida W, Shirasawa H, Snijders PJ, Stoler MH, Suárez-Rincón AE, Szarka K, Tachezy R, Ueda M, van der Zee AG, von Knebel Doeberitz M, Wu MT, Yamashita T, Zehbe I, Blettner M (2009) TP53 codon 72 polymorphism and cervical cancer: a pooled analysis of individual data from 49 studies. Lancet Oncol 10:772–784

    Article  CAS  PubMed  Google Scholar 

  • Yeh CC, Sung FC, Tang R, Chang-Chieh CR, Hsieh LL (2007) Association between polymorphisms of biotransformation and DNA-repair genes and risk of colorectal cancer in Taiwan. J Biomed Sci 14:183–193

    Article  CAS  PubMed  Google Scholar 

  • Agudo A, Sala N, Pera G, Capellá G, Berenguer A, García N, Palli D, Boeing H, Del Giudice G, Saieva C, Carneiro F, Berrino F, Sacerdote C, Tumino R, Panico S, Berglund G, Simán H, Stenling R, Hallmans G, Martínez C, Bilbao R, Barricarte A, Navarro C, Quirós JR, Allen N, Key T, Bingham S, Khaw KT, Linseisen J, Nagel G, Overvad K, Tjonneland A, Olsen A, Bueno-de-Mesquita HB, Boshuizen HC, Peeters PH, Numans ME, Clavel-Chapelon F, Boutron-Ruault MC, Trichopoulou A, Lund E, Offerhaus J, Jenab M, Ferrari P, Norat T, Riboli E, González CA (2006) Polymorphisms in metabolic genes related to tobacco smoke and the risk of gastric cancer in the European prospective investigation into cancer and nutrition. Cancer Epidemiol Biomarkers Prev 15:2427–2434

    Article  CAS  PubMed  Google Scholar 

  • Yeh CC, Sung FC, Tang R, Chang-Chieh CR, Hsieh LL (2009) Polymorphisms of cytochrome P450 1A2 and N-acetyltransferase genes, meat consumption, and risk of colorectal cancer. Dis Colon Rectum 52:104–111

    Article  PubMed  Google Scholar 

  • Shimada N, Iwasaki M, Kasuga Y, Yokoyama S, Onuma H, Nishimura H, Kusama R, Hamada GS, Nishimoto IN, Iyeyasu H, Motola J Jr, Laginha FM, Kurahashi N, Tsugane S (2009) Genetic polymorphisms in estrogen metabolism and breast cancer risk in case–control studies in Japanese, Japanese Brazilians and non-Japanese Brazilians. J Hum Genet 54:209–215

    Article  CAS  PubMed  Google Scholar 

  • Yoshida K, Osawa K, Kasahara M, Miyaishi A, Nakanishi K, Hayamizu S, Osawa Y, Tsutou A, Tabuchi Y, Shimada E, Tanaka K, Yamamoto M, Takahashi J (2007) Association of CYP1A1, CYP1A2, GSTM1 and NAT2 gene polymorphisms with colorectal cancer and smoking. Asian Pac J Cancer Prev 8:438–444

    PubMed  Google Scholar 

  • Zhenzhen L, Xianghua L, Ning S, Zhan G, Chuanchuan R, Jie L (2013) Current evidence on the relationship between three polymorphisms in the CYP1A2 gene and the risk of cancer. Eur J Cancer Prev 22:607–619

    Article  PubMed  Google Scholar 

  • Zienolddiny S, Campa D, Lind H, Ryberg D, Skaug V, Stangeland LB, Canzian F, Haugen A (2008) Acomprehensive analysis of phase I and phase II metabolism gene polymorphisms and risk of non-small cell lung cancer in smokers. Carcinogenesis 29:1164–1169

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgments

Wen-Xia Zhang and Ying-Hua Chen contributed equally to this study and should be considered as co-first authors. This study was supported by the Natural Science Foundation of Shanxi Province (2013011056-3), The Science and Technology Development Projects of Colleges and Universities of Shanxi Province (20121013), and The Scientific Research Subject of the Health Department of Shanxi Province (201202008).

Conflict of interest

None.

Author information

Authors and Affiliations

  1. Department of Gynecology, Peace Hospital of Changzhi Medical College, Changzhi, Shanxi, 046000, People’s Republic of China

    Wen-Xia Sun

  2. Division of Histology and Embryology, School of Basic Medical Sciences, Southern Medical University, Guangzhou, Guangdong, 510515, China

    Ying-Hua Chen & Lin Zhang

  3. Department of Gastroenterology, The Second People’s Hospital of Zhuhai, Zhuhai, Guangdong, 519000, People’s Republic of China

    Zhi-Zhong Liu, Jian-Jun Xie, Wei Wang, Ya-Ping Du & Yu Chen

  4. Department of Hematology, Peace Hospital of Changzhi Medical College, Changzhi, Shanxi, 046000, People’s Republic of China

    Xu-Liang Shen & Wu Wei

  5. Department of Research, Peace Hospital of Changzhi Medical College, Changzhi, Shanxi, 046000, People’s Republic of China

    Xiao-Feng He & Li-Xia Wu

Authors
  1. Wen-Xia Sun
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Ying-Hua Chen
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Zhi-Zhong Liu
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Jian-Jun Xie
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Wei Wang
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Ya-Ping Du
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Yu Chen
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Xu-Liang Shen
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Xiao-Feng He
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Li-Xia Wu
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. Wu Wei
    View author publications

    You can also search for this author in PubMed Google Scholar

  12. Lin Zhang
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding authors

Correspondence to Xiao-Feng He, Wu Wei or Lin Zhang.

Additional information

Communicated by S. Hohmann.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Sun, WX., Chen, YH., Liu, ZZ. et al. Association between the CYP1A2 polymorphisms and risk of cancer: a meta-analysis. Mol Genet Genomics 290, 709–725 (2015). https://doi.org/10.1007/s00438-014-0956-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00438-014-0956-8

Keywords

Search

Navigation